Emerging Technologies
The Japanese manufacturer's new company, established in Delaware, will utilize a cell picking and imaging system to help providers detect and treat diseases.
Utilizing AI and machine learning, the Charge 6 supplies up to 60% more accurate heart rate readings, the most precise in a Fitbit tracker yet.
The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.
The company will use the funds to expand its reach throughout hospitals in the U.S. and enhance product development.
The company will use the funds to expand internationally, initially focused on the Japanese and Brazilian markets.
Data exchange platform Briya and clinical trial-participant management platform Mural Health also secured investments.
The funds will be used to develop AI-enabled ultrasound technology for maternal care and pediatric lung health in low- and middle-income countries.
The pair will work to further the practice of radiology and patient care using innovation, such as theranostics, AI and digital health platforms.
The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.
Fifteen projects, including eight digital health initiatives, received $3 million in cash, Google Cloud credits and technical assistance.